癌症中的光动力疗法:对细胞和分子通路的洞察
Vincenzo Papa1, Fabiana Furci2, Paola Lucia Minciullo1
1Allergy and Clinical Immunology Unit, Department of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria, 98125 Messina, Italy.
Current issues in molecular biology
|February 25, 2025
概括
光动力学疗法使用光和光敏剂来产生单片氧,有效地杀死癌细胞. 这种创新的治疗方法对改善癌症护理和精准医学有很大的前景.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 纳米技术 纳米技术
背景情况:
- 光动力疗法 (PDT) 是一种非电离辐射治疗.
- PDT使用光敏剂和光来产生单片氧.
- 单一氧气通过亡,亡或瘤细胞的自产生抗癌作用.
研究的目的:
- 提供一篇关于光动力学治疗的最先进的评论.
- 阐明参与PDT的细胞分子机制和途径.
- 探索PDT与纳米技术的整合,以改善癌症治疗.
主要方法:
- 关于光动力学治疗的当前文献的综述.
- 对细胞分子机制和信号通路的分析.
- 纳米技术的最新进展与PDT原则的整合.
主要成果:
- 通过直接的细胞死亡和微血管损伤,PDT有效地准瘤细胞.
- PDT诱导局部炎症反应,有助于抗癌效应.
- 将PDT与纳米技术相结合,可以增强其治疗潜力.
结论:
- 光动力疗法是一种有价值的非侵入性方法,用于治疗各种癌症,特别是早期瘤.
- 了解PDT的细胞分子机制对于优化治疗策略至关重要.
- 纳米技术与PDT的整合为瘤学中的精准医学提供了一个有希望的途径.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
01:27Tumor Immunotherapy
463
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463
02:34Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
02:15M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K